{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:00:04Z","timestamp":1791406804226,"version":"4.3.3"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.medmal.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T02:01:47Z","timestamp":1329357707000},"page":"126-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["C\u00e9foxitine et BLSE"],"prefix":"10.1016","volume":"42","author":[{"given":"M.","family":"Boyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dessein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Guery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kipnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.medmal.2012.01.004_bib0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","article-title":"Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae changing epidemiology and drug treatment choices","volume":"70","author":"Pitout","year":"2010","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.medmal.2012.01.004_bib0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/AAC.6.3.290","article-title":"Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology","volume":"6","author":"Brumfitt","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.medmal.2012.01.004_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/1.1.1","article-title":"Editorial and introduction","volume":"1","author":"Kass","year":"1979","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2012.01.004_bib0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/clinids\/1.1.144","article-title":"Comparative studies of cefoxitin and cephalothin: an overview","volume":"1","author":"Neu","year":"1979","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.medmal.2012.01.004_bib0025","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/AAC.15.6.792","article-title":"Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases","volume":"15","author":"Sanders","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2012.01.004_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/00222615-21-3-203","article-title":"Cefoxitin sensitivity as a marker for inducible beta-lactamases","volume":"21","author":"Moritz","year":"1986","journal-title":"J Med Microbiol"},{"issue":"5","key":"10.1016\/j.medmal.2012.01.004_bib0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/infdis\/159.5.1005","article-title":"In vivo selection of a cephamycin-resistant porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3\u00a0beta-lactamase","volume":"159","author":"Pangon","year":"1989","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.medmal.2012.01.004_bib0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00000658-198103000-00018","article-title":"Use of peroperative cefoxitin to prevent infection after colonic and rectal surgery","volume":"193","author":"Hoffmann","year":"1981","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.medmal.2012.01.004_bib0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/BF02013110","article-title":"Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins","volume":"6","author":"Dworzack","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.medmal.2012.01.004_bib0050","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/jac\/dkl381","article-title":"Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates","volume":"58","author":"Lee","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X12000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X12000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:10:47Z","timestamp":1759972247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X12000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0399077X12000157"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2012.01.004","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C\u00e9foxitine et BLSE","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2012.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}